ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV unmutated chronic lymphocytic leukemia

Abstract

Expression of ZAP-70 in a subset of CLL patients positively correlates with the absence of IGHV mutations and is indicative of a more active disease and shorter treatment free survival. We recently demonstrated that ZAP-70 regulates the constitutive expression of CCL3 and CCL4, activation of AKT and expression of MYC in the absence of an overt BCR signal, bona fide functions of BCR activation. We here provide evidence that these features relate to the presence of a constitutive tonic BCR signal, exclusively found in IGHV unmutated CLL and dependent on the ZAP-70 mediated activation of AKT and its downstream target GSK3b. These findings are associated with increased steady state activation of CD19 and SRC. Notably this tonic BCR signal is not present in IGHV mutated CLL cells, discordantly expressing ZAP-70. Quantitative mass spectrometry and phosphoprotein-analyses indicate that this ZAP-70-dependent, tonic BCR-signal regulates CLL cell migration through phosphorylation of LCP1 on serine-5. Indeed, we show that CCL19- and CCL21-induced chemotaxis is regulated by and dependent on the expression of ZAP-70 through its function to enhance CCR7 signaling to LCP1. Thus, our data demonstrate that ZAP-70 converges a tonic BCR signal, exclusively present in IGHV unmutated CLL, and CCR7-mediated chemotaxis.